PAROXetine (as HCl) Tablet
PAROXetine (as HCl) is a compounded formulation containing PAROXetine, prepared by Mixlab for veterinary use. Available by prescription.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Paroxetine hydrochloride is a selective serotonin reuptake inhibitor (SSRI) utilized in veterinary medicine for behavioral management. It is a prescription medication available for use in dogs and cats, requiring a valid veterinarian-client-patient relationship before it can be dispensed. It is frequently considered in the context of behavioral health for managing chronic stress-related challenges.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it is considered to influence serotonin signaling within the central nervous system, providing a method for modulating emotional responses. Commonly observed effects include behavioral shifts such as lethargy or coordination changes and localized digestive changes like vomiting. Because it influences neurological pathways, your veterinarian will monitor for observational signs of sensitivity. Owners should monitor for significant behavioral shifts and contact their veterinarian promptly with any concerns regarding the patient's response to the medication.
Yes. Paroxetine HCl is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all professional authorizations before preparing any medication.
Yes. Mixlab specializes in compounding paroxetine hydrochloride into customized strengths and flavored oral formats, such as flavored oral liquids or treats, to suit the specific needs of your pet.
Veterinarians discuss paroxetine because it is considered to influence the neurotransmitters associated with mood and arousal. This provides a method for addressing your pet's behavioral responses during recovery.
Sedation and lethargy are commonly observed effects of SSRIs. Your veterinarian will provide guidance on what level of drowsiness is expected and how to monitor your pet's energy levels during use.
Significant interactions can occur with other medications that influence serotonin. Your veterinarian will determine the most appropriate protocol based on your pet's complete health and medication history.
